标题
Pros and cons of current brain tumor imaging
作者
关键词
-
出版物
NEURO-ONCOLOGY
Volume 16, Issue suppl 7, Pages vii2-vii11
出版商
Oxford University Press (OUP)
发表日期
2014-10-14
DOI
10.1093/neuonc/nou224
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme
- (2014) Paul Sanghera et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma
- (2014) M. Nowosielski et al. NEUROLOGY
- Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
- (2013) Olivier L. Chinot et al. Current Neurology and Neuroscience Reports
- Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study
- (2013) J. L. Boxerman et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
- (2013) Q. T. Ostrom et al. NEURO-ONCOLOGY
- FLAIR-Only Progression in Bevacizumab-Treated Relapsing Glioblastoma Does Not Predict Short Survival
- (2013) Christina Schaub et al. ONCOLOGY
- Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging
- (2013) Hee Ho Chu et al. RADIOLOGY
- Probabilistic Radiographic Atlas of Glioblastoma Phenotypes
- (2012) B.M. Ellingson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria
- (2012) J. G. Perez-Larraya et al. NEURO-ONCOLOGY
- Standards of care for treatment of recurrent glioblastoma—are we there yet?
- (2012) Michael Weller et al. NEURO-ONCOLOGY
- Percent Change of Perfusion Skewness and Kurtosis: A Potential Imaging Biomarker for Early Treatment Response in Patients with Newly Diagnosed Glioblastomas
- (2012) Hye Jin Baek et al. RADIOLOGY
- Response Assessment in Neuro-Oncology Criteria: Implementation Challenges in Multicenter Neuro-Oncology Trials
- (2011) W.B. Pope et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
- (2011) L.C. Hygino da Cruz et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy
- (2011) Whitney B. Pope et al. Current Neurology and Neuroscience Reports
- Patterns of Progression in Malignant Glioma Following Anti-VEGF Therapy: Perceptions and Evidence
- (2011) Wolfgang Wick et al. Current Neurology and Neuroscience Reports
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria
- (2011) A. Radbruch et al. NEURO-ONCOLOGY
- Clinical trial end points for high-grade glioma: the evolving landscape
- (2011) D. A. Reardon et al. NEURO-ONCOLOGY
- Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab
- (2011) W. B. Pope et al. NEUROLOGY
- Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
- (2011) R. J. Young et al. NEUROLOGY
- Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
- (2011) Pascal O. Zinn et al. PLoS One
- Monitoring Radiographic Brain Tumor Progression
- (2011) Ankit I. Mehta et al. Toxins
- Bevacizumab does not increase the risk of remote relapse in malignant glioma
- (2010) Antje Wick et al. ANNALS OF NEUROLOGY
- Bevacizumab and Irinotecan in the Treatment of Recurrent Malignant Gliomas
- (2010) John F. de Groot et al. CANCER JOURNAL
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiographic patterns of relapse in glioblastoma
- (2010) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
- (2010) M. Prados et al. NEURO-ONCOLOGY
- Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
- (2010) Rajiv Mangla et al. RADIOLOGY
- Response Assessment in Neuro-Oncology
- (2010) Eudocia C. Quant et al. Current Oncology Reports
- Bidimensional Measurements in Brain Tumors: Assessment of Interobserver Variability
- (2009) James M. Provenzale et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression
- (2009) Elizabeth R. Gerstner et al. JOURNAL OF NEURO-ONCOLOGY
- CNS complications of radiotherapy and chemotherapy
- (2009) Carole Soussain et al. LANCET
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
- (2009) F. M. Iwamoto et al. NEUROLOGY
- Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
- (2009) Ramon F. Barajas et al. RADIOLOGY
- Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations
- (2009) Cristo Chaskis et al. SURGICAL NEUROLOGY
- Brain Tumor Imaging in Clinical Trials
- (2008) J.W. Henson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
- (2008) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
- (2008) Felix Bokstein et al. CANCER
- Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
- (2008) Walter Taal et al. CANCER
- MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
- (2008) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
- (2008) Sith Sathornsumetee et al. JOURNAL OF CLINICAL ONCOLOGY
- Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety
- (2008) Tyler Y. Kang et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
- (2008) R. M. Zuniga et al. JOURNAL OF NEURO-ONCOLOGY
- Time course of imaging changes of GBM during extended bevacizumab treatment
- (2008) Suchitra Ananthnarayan et al. JOURNAL OF NEURO-ONCOLOGY
- Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
- (2008) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
- (2008) Dieta Brandsma et al. LANCET ONCOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- Relationship between Gene Expression and Enhancement in Glioblastoma Multiforme: Exploratory DNA Microarray Analysis
- (2008) Whitney B. Pope et al. RADIOLOGY
- Response criteria for glioma
- (2008) A Gregory Sorensen et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now